Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

被引：0
|
作者：
Ahmad, Bilal [1 ]
Maymani, Hossein [1 ]
Saeed, Haseeb [1 ]
Khawandanah, Mohamad [1 ]
Srour, Samer A. [1 ]
Machiorlatti, Michael G. [2 ]
Asch, Adam S. [1 ]
Cherry, Mohamad [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Shi, J
    Erder, MH
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1997, 90 (10) : 314 - 314
  • [22] Trisomy 8 in acute myeloid leukemia: Impact on clinical presentation and outcome
    Thomas, Xavier
    Jaff, Nabaz
    Chelghoum, Youcef
    Elhamri, Mohamed
    Tigaud, Isabelle
    Michallet, Mauricette
    ANNALS OF ONCOLOGY, 2006, 17 : 204 - 204
  • [23] Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients
    Yalniz, Fevzi F.
    Johnson, Anna
    Alnimer, Yanal
    Chahine, Zena
    Morris, Trevor
    Yadav, Rina
    Taj, Hiffsa
    Iragavarapu, Chaitanya
    Munker, Reinhold
    Monohan, Gregory
    Wai, Sainan
    Zhang, Shulin
    Nozad, Sahar
    Qasrawi, Ayman
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (02) : 365 - 372
  • [24] Correlation of KIT expression with higher FLT3 mutations and impact on clinical outcome in patients newly diagnosed with acute myeloid leukemia (AML).
    Alkhateeb, Hassan
    Litzow, Mark Robert
    Baidoun, Firas
    Hashmi, Shahrukh
    Hogan, William J.
    Patnaik, Mrinal M.
    Elliott, Michelle A.
    Chen, Dong
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Code status transitions in patients with high-risk acute myeloid leukemia (AML).
    Abrams, Hannah Rebeccah
    Nipp, Ryan David
    Traeger, Lara
    Lavoie, Mitchell W.
    Reynolds, Matthew J.
    LeBlanc, Thomas William
    El-Jawahri, Areej
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Code Status Transitions in Patients with High-Risk Acute Myeloid Leukemia (AML)
    Abrams, Hannah R.
    Nipp, Ryan D.
    Traeger, Lara
    Lavoie, Mitchell W.
    Reynolds, Matthew J.
    LeBlanc, Thomas W.
    El-Jawahri, Areej
    BLOOD, 2021, 138
  • [27] Impact of Insurance Status and Distance from Residence to Treatment Center on the Outcomes of Patients Diagnosed with Acute Myeloid Leukemia
    Al Mahmasani, Layal
    Mahmoud, Maya
    Charafeddine, Maya
    El Cheikh, Jean
    Bazarbachi, Ali
    Abou Dalle, Iman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S294 - S294
  • [28] The Impact of Chromothripsis on the Clinical Outcomes of Acute Myeloid Leukemia (AML): A Meta-Analysis
    Haddad, Philip A.
    Hammoud, Dalia
    Gallagher, Kevin M.
    BLOOD, 2020, 136
  • [29] Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia
    H Lapillonne
    L Llopis
    A Auvrignon
    A Renneville
    M Labopin
    F Mazingue
    C Perot
    J-L Lai
    N Philippe
    P Ballerini
    V Zurawski
    M Adam
    L Douay
    G Leverger
    J Landman-Parker
    C Preudhomme
    Leukemia, 2010, 24 : 205 - 209
  • [30] Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia
    Lapillonne, H.
    Llopis, L.
    Auvrignon, A.
    Renneville, A.
    Labopin, M.
    Mazingue, F.
    Perot, C.
    Lai, J-L
    Philippe, N.
    Ballerini, P.
    Zurawski, V.
    Adam, M.
    Douay, L.
    Leverger, G.
    Landman-Parker, J.
    Preudhomme, C.
    LEUKEMIA, 2010, 24 (01) : 205 - 209
12345